A new review underscores the complexity of modelling diabetic neuropathic pain, highlighting variability in animal models and calling for more nuanced phenotyping to improve translation to human conditions. A new review in Dove Press says the central challenge in diabetic…
A model based on NHS England’s approach indicates that structured lifestyle interventions could improve health outcomes and save costs in Canada, though benefits vary with age and duration of effect. A diabetes prevention programme modelled on the NHS England approach…
Emerging evidence highlights exercise not just as lifestyle advice but as a recognised and essential part of long-term disease management, tailored to individual needs to optimise health outcomes. Exercise is increasingly being treated as more than a lifestyle choice in…
Research presented at the European Association for the Study of Diabetes highlights that moderate-to-vigorous activity, especially later in the day, significantly reduces type 2 diabetes risk among younger adults, with age-related differences in benefits. A larger amount of moderate-to-vigorous physical…
While GLP-1 receptor agonists are revolutionising obesity treatment, clinicians emphasise that sustained success hinges on diet, exercise, and long-term behavioural changes, as recent studies and patient experiences highlight the importance of a comprehensive approach. GLP-1 medicines may have transformed weight-loss…
While alcohol does not diminish the effectiveness of oral GLP-1 drugs for obesity, it can heighten side effects and complicate treatment, experts caution, recommending careful management rather than outright abstinence. Alcohol does not appear to blunt the effect of oral…
Brazil’s health regulator, Anvisa, has ordered the suspension of multiple insulin, tirzepatide, and peptide products sold without proper authorisation, targeting unlicensed online sales and unregistered manufacturers amidst ongoing regulatory crackdowns. Brazil’s health regulator has ordered the suspension of sales of…
Recent advances in insulin technology highlighted at the EASD meeting demonstrate a shift towards personalised, convenient, and rapid-acting treatments, with new formulations and delivery methods aiming to enhance daily diabetes management. At this year’s European Association for the Study of…
Dexcom’s fifth season of Dexcom U features its largest roster yet, highlighting a shift in attitudes towards diabetes in sports, with more young athletes participating confidently and supported by advanced continuous glucose monitoring technology. Dexcom has launched the fifth season…
Dexcom’s fifth season of Dexcom U features a record roster of 27 college athletes and underscores a growing shift in perceptions, support, and participation among young athletes living with diabetes. Dexcom has opened the fifth season of Dexcom U, its…
